^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SDS-19CAR

i
Other names: SDS-19CAR, anti-CD19 chimeric antigen receptor T cell therapy
Associations
Trials
Company:
Innovative Cellular Therapeutics
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials